These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 10869771

  • 1. Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy.
    Eyles JE, Williamson ED, Spiers ID, Alpar HO.
    Vaccine; 2000 Aug 01; 18(28):3266-71. PubMed ID: 10869771
    [Abstract] [Full Text] [Related]

  • 2. Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines.
    Eyles JE, Spiers ID, Williamson ED, Alpar HO.
    Vaccine; 1998 Dec 01; 16(20):2000-9. PubMed ID: 9796057
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.
    Goodin JL, Nellis DF, Powell BS, Vyas VV, Enama JT, Wang LC, Clark PK, Giardina SL, Adamovicz JJ, Michiel DF.
    Protein Expr Purif; 2007 May 01; 53(1):63-79. PubMed ID: 17293124
    [Abstract] [Full Text] [Related]

  • 7. Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration.
    Eyles JE, Bramwell VW, Williamson ED, Alpar HO.
    Vaccine; 2001 Sep 14; 19(32):4732-42. PubMed ID: 11535324
    [Abstract] [Full Text] [Related]

  • 8. Immunisation against plague by transcutaneous and intradermal application of subunit antigens.
    Eyles JE, Elvin SJ, Westwood A, Lebutt CS, Alpar HO, Somavarapu S, Williamson ED.
    Vaccine; 2004 Oct 22; 22(31-32):4365-73. PubMed ID: 15474730
    [Abstract] [Full Text] [Related]

  • 9. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.
    Williamson ED, Vesey PM, Gillhespy KJ, Eley SM, Green M, Titball RW.
    Clin Exp Immunol; 1999 Apr 22; 116(1):107-14. PubMed ID: 10209513
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis.
    Reddin KM, Easterbrook TJ, Eley SM, Russell P, Mobsby VA, Jones DH, Farrar GH, Williamson ED, Robinson A.
    Vaccine; 1998 May 22; 16(8):761-7. PubMed ID: 9627932
    [Abstract] [Full Text] [Related]

  • 11. Intranasal vaccination against plague, tetanus and diphtheria.
    Alpar HO, Eyles JE, Williamson ED, Somavarapu S.
    Adv Drug Deliv Rev; 2001 Sep 23; 51(1-3):173-201. PubMed ID: 11516788
    [Abstract] [Full Text] [Related]

  • 12. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.
    Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS.
    Vaccine; 2006 Mar 06; 24(10):1625-32. PubMed ID: 16243411
    [Abstract] [Full Text] [Related]

  • 13. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
    Tripathi V, Chitralekha KT, Bakshi AR, Tomar D, Deshmukh RA, Baig MA, Rao DN.
    Vaccine; 2006 Apr 12; 24(16):3279-89. PubMed ID: 16476510
    [Abstract] [Full Text] [Related]

  • 14. Protection against plague following immunisation with microencapsulated V antigen is reduced by co-encapsulation with IFN-gamma or IL-4, but not IL-6.
    Griffin KF, Eyles JE, Spiers ID, Alpar HO, Williamson ED.
    Vaccine; 2002 Nov 01; 20(31-32):3650-7. PubMed ID: 12399192
    [Abstract] [Full Text] [Related]

  • 15. Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine.
    Elvin SJ, Eyles JE, Howard KA, Ravichandran E, Somavarappu S, Alpar HO, Williamson ED.
    Vaccine; 2006 May 15; 24(20):4433-9. PubMed ID: 16546306
    [Abstract] [Full Text] [Related]

  • 16. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A, Hanada Y, Khalifé M, Carniel E, Demeure CE.
    PLoS Negl Trop Dis; 2015 May 15; 9(10):e0004162. PubMed ID: 26473734
    [Abstract] [Full Text] [Related]

  • 17. A single dose sub-unit vaccine protects against pneumonic plague.
    Williamson ED, Eley SM, Stagg AJ, Green M, Russell P, Titball RW.
    Vaccine; 2000 Oct 15; 19(4-5):566-71. PubMed ID: 11027822
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
    Honko AN, Sriranganathan N, Lees CJ, Mizel SB.
    Infect Immun; 2006 Feb 15; 74(2):1113-20. PubMed ID: 16428759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.